Currently, Hilde Windels occupies the position of Executive Chairman & Co-Chief Executive Officer at MyCartis NV and Chief Executive Officer of Antelope Dx BV. Ms. Windels is also on the board of ERYTech Pharma SA, Celyad Oncology SA and Windels Hilde Bvba.

Ms. Windels previously occupied the position of Executive Director at Biocartis Group NV and Co-Chief Executive Officer of Biocartis SA (a subsidiary of Biocartis Group NV), Chief Financial Officer at SEPS Pharma NV, Chief Financial Officer & Director at deVGen NV and Manager for ING Belgium SA.

Hilde Windels received a graduate degree from Katholieke Universiteit Leuven.